Kanagawa, Japan

Shigeo Takada

This inventor holds 1 USPTO granted patent. Top assignee: Amato Pharmaceutical Products, Ltd.. Active years: 2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shigeo Takada. Retrieved from https://idiyas.com/inventor/shigeo-takada

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Shigeo Takada: Innovator in Diabetes Treatment

Introduction: Shigeo Takada is a notable inventor based in Kanagawa, Japan. He has made significant contributions to the field of medicine, particularly in the treatment of diabetes. His innovative approach has led to the development of a unique medicament aimed at preventing and treating diabetes and its complications.

Latest Patents: Takada holds 1 patent for his invention titled "Remedies for diabetes." The primary objective of this patent is to provide a medicament that effectively reduces blood sugar levels. The invention comprises a mixture of cyclic and/or straight chain poly lactic acids with a condensation degree of 3 to 19, showcasing a novel method for managing diabetes.

Career Highlights: Shigeo Takada is associated with Amato Pharmaceutical Products, Ltd., where he continues to work on innovative solutions in the pharmaceutical industry. His dedication to research and development has positioned him as a key figure in the fight against diabetes.

Collaborations: Throughout his career, Takada has collaborated with esteemed colleagues, including Yasukazu Nagato and Masahiro Murakami. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries in diabetes treatment.

Conclusion: Shigeo Takada's contributions to diabetes treatment through his innovative patent demonstrate his commitment to improving health outcomes. His work continues to inspire advancements in medical science and offers hope for those affected by diabetes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…